header logo image

Renal Insufficiency May Be Associated With Impaired Regenerative Capacity in CAD – The Cardiology Advisor

April 1st, 2020 6:41 am

The following article is part of conference coverage from the American College of Cardiology (ACC.20) /World Congress of Cardiology. The Cardiology Advisors staff is reporting on research conducted by leading experts in cardiology. Check back for the latest news from the ACC.20.

Renal insufficiency may be linked to reduced circulating progenitor cell (CPC) counts, a factor indicative of impaired regenerative capacity in older adults with coronary artery disease (CAD), according to study results intended to be presented at the annual meeting of the American College of Cardiology (ACC 2020).

Anurag Mehta, MBBS, from the Emory University School of Medicine, Atlanta, Georgia, and colleagues estimated the number of CPCs with flow cytometry. CPCs were CD45med+ cells with a single nucleus expressing epitopes for CD34 and CD133. The samples of 1281 patients with CAD (mean age, 66 years; 39% women; 21% black) were analyzed. The association between renal insufficiency (ie, estimated glomerular filtration rate <60 mL/min/1.73 m2) and log-transformed CPC counts was examined using adjusted linear regression models. Furthermore, using adjusted Cox models, the investigators assessed the predictive value of CPC counts for cardiovascular death or myocardial infarction during a 3.5-year median follow-up period.

In unadjusted analyses renal insufficiency wasfound to be associated with lower counts of CD34+ cells (-10.1%; 95%CI, -16.9% to -2.8%; P =.008) and withlower counts of CD34+/CD133+ cells (-11.4%; 95% CI,-19.4% to -2.6%; P =.13) in 446patients.

After adjusting for age, renal insufficiencywas independently associated with lower counts of CD34+ cells (14.5%;95% CI, -24.4% to -3.4%; P =.012) andwith lower counts of CD34+/CD133+ cells (-15.7%; 95% CI,-28.7% to -0.4%; P =.045) in patients70 years. Patients with renal insufficiency who had counts below the medianfor CD34+ or CD34+/CD133+ cells were found tobe at a higher risk for adverse events (adjusted hazard ratio, 1.76; 95% CI,1.24-2.52 and adjusted hazard ratio, 1.80; 95% CI, 1.26-2.56, respectively).Notably, patients with renal insufficiency and CPC counts above the medianvalue had a similar risk for cardiovascular death or myocardial infarctioncompared with patients without renal insufficiency.

The investigators concluded, Impairedregenerative capacity in patients with CAD and [renal insufficiency] independentlypredicts cardiovascular risk.

Reference

Mehta A, Tahhan AS, Liu C, et al. Impaired regenerative capacity predicts outcomes in patients with coronary artery disease and renal insufficiency. Intended to be presented at: American College of Cardiology 69th Annual Scientific Session; March 28-30, 2020; Chicago, IL. Presentation 915-07. Accessed March 24, 2020.

Visit The Cardiology Advisors conference section for coverage intended to be presented at the annual meeting of the American College of Cardiology (ACC.20)/World Congress of Cardiology

See the original post:
Renal Insufficiency May Be Associated With Impaired Regenerative Capacity in CAD - The Cardiology Advisor

Related Post

Comments are closed.


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick